Page 9 of 15
New Journal of Chemistry
Please do not adjust margins
Journal Name
N-Ferrocenyl-4-nitrobenzamide
ARTICLE
1
2
3
4
5
6
7
8
(
2-4NO2). The general 4F (eluent: petroleum ether-AcOEt 70:30; Rf = 0.80) in 79%
DOI: 10.1039/D0NJ03470C
procedure 1 starting from 4-nitrobenzamide (0.18 g) gave 2- yield (0.27 g) as an orange solid: mp 211-213 °C; IR (ATR) 671,
4NO2 (eluent: petroleum ether-AcOEt 70:30; Rf = 0.60) in 56% 723, 758, 807, 836, 857, 893, 931, 998, 1024, 1037, 1096,
yield (0.21 g) as a dark purple solid: mp 242-245 °C; IR (ATR) 1104, 1124, 1159, 1229, 1282, 1300, 1310, 1349, 1367, 1389,
710, 738, 802, 824, 851, 867, 895, 928, 1105, 1278, 1341, 1408, 1477, 1505, 1561, 1601, 1640, 3109, 3272 cm-1; H NMR
1
1365, 1387, 1494, 1519, 1552, 1600, 1645, 2924, 3317 cm-1; 1H ((CD3)2SO)
4.01 (t, 2H, J = 1.6 Hz, H3 and H4), 4.13 (s, 5H, Cp),
4.05 (t, 2H, J = 1.7 Hz, H3 and H4), 4.15 (s, 4.79 (t, 2H, J = 1.6 Hz, H2 and H5), 7.34 (t, 2H, J = 8.9 Hz, H3’
5H, Cp), 4.81 (t, 2H, J = 1.7 Hz, H2 and H5), 8.14 (d, 2H, J = 8.7 and H5’), 7.99 (dd, 2H, J = 8.7 and 5.6 Hz, H2’ and H6’), 9.74 (br
Hz, H2’ and H6’), 8.35 (d, 2H, J = 8.7 Hz, H3’ and H5’), 10.09 (br s, 1H, NH); 13C NMR ((CD3)2SO)
61.1 (2CH, C2 and C5), 63.9
s, 1H, NH); 13C NMR ((CD3)2SO)
61.4 (2CH, C2 and C5), 64.2 (2CH, C3 and C4), 68.8 (5CH, Cp), 95.7 (C, C1, C-N), 115.2 (d,
NMR ((CD3)2SO)
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(2CH, C3 and C4), 68.9 (5CH, Cp), 95.1 (C, C1, C-N), 123.5 (2CH, 2CH, J = 21.8 Hz, C3’ and C5’), 130.0 (d, 2CH, J = 9.1 Hz, C2’ and
C3’ and C5’), 128.9 (2CH, C2’ and C6’), 140.3 (C, C1’, C-C=O), C6’), 131.2 (d, C, J = 2.3 Hz, C1’, C-C=O), 163.8 (C, C=O), 163.9
149.0 (C, C4’, C-NO2), 163.1 (C, C=O). Crystal data for 2-4NO2. (d, C, J = 249 Hz, C4’, C-F); MS (EI, 70 eV): 323 [M], 258 [M-Cp].
C17H14FeN2O3, M = 350.15, orthorhombic, P b c n, a = Crystal data for 2-4F. C17H14FFeNO, M = 323.14, monoclinic, P
18.433(3), b = 10.1869(16), c = 15.329(3) Å, V = 2878.4(9) Å3, Z 21/c, a = 10.7882(11), b = 14.3983(13), c = 9.0245(9) Å,
=
= 8, d = 1.616 g cm-3, μ = 1.065 mm-1. A final refinement on F2 102.111(4) °, V = 1370.6(2) Å3, Z = 4, d = 1.566 g cm-3, μ = 1.108
with 3282 unique intensities and 212 parameters converged at mm-1. A final refinement on F2 with 3149 unique intensities
ωR(F2) = 0.0899 (R(F) = 0.0353) for 2721 observed reflections and 193 parameters converged at ωR(F2) = 0.0631 (R(F) =
with I > 2σ(I). CCDC 2014641.
N-Ferrocenyl-3-methoxybenzamide
procedure 1, but on a 2 mmol scale, starting from 3-
0.0248) for 2895 observed reflections with I > 2σ(I). CCDC
2-3OMe). The general 2014643.
N-Ferrocenyl-2-methylbenzamide
(
(2-2Me). The general
methoxybenzamide (0.34 g) gave 2-3OMe (eluent: petroleum procedure 1 starting from 2-methylbenzamide (0.15 g) gave 2-
ether-AcOEt 90:10; Rf = 0.25) in 80% yield (0.56 g) as an 2Me (eluent: petroleum ether-AcOEt 70:30; Rf = 0.73) in 63%
orange solid: mp 160-161 °C; IR (ATR) 692, 713, 749, 806, 825, yield (0.21 g) as an orange solid: mp 186-188 °C; IR (ATR) 670,
866, 880, 899, 921, 932, 1002, 1036, 1076, 1108, 1184, 1228, 701, 726, 793, 815, 926, 1008, 1028, 1055, 1105, 1131, 1155,
1257, 1281, 1351, 1366, 1385, 1450, 1472, 1490, 1553, 1581, 1180, 1223, 1293, 1333, 1354, 1368, 1402, 1422, 1446, 1487,
1600, 1635, 2837, 2972, 3104, 3332 cm-1; H NMR (CDCl3)
1574, 1598, 1628, 2933, 3094 cm-1; H NMR (CDCl3)
2.51 (s,
1
1
3.87 (s, 3H, OMe), 4.07 (t, 2H, J = 1.8 Hz, H3 and H4), 4.20 (s, 3H, Me), 4.05 (t, 2H, J = 1.8 Hz, H3 and H4), 4.21 (s, 5H, Cp),
5H, Cp), 4.74 (t, 2H, J = 1.8 Hz, H2 and H5), 7.07 (ddd, 1H, J = 4.71 (t, 2H, J = 1.8 Hz, H2 and H5), 6.86 (br s, 1H, NH), 7.21-
8.0, 2.6 and 1.3 Hz, Ar), 7.21 (br s, 1H, NH), 7.31 (dd, 1H, J = 7.7 7.24 (m, 1H, Ar), 7.26-7.27 (m, 1H, H3’), 7.33 (dd, 1H, J = 7.3
and 1.3 Hz, Ar), 7.34-7.41 (m, 2H, Ar); 13C NMR (CDCl3)
55.7 and 1.2 Hz, Ar), 7.39 (d, 1H, J = 7.6 Hz, H6’); 13C NMR (CDCl3)
(CH3, OMe), 61.8 (2CH, C2 and C5), 64.9 (2CH, C3 and C4), 69.4 20.0 (CH3), 61.7 (2CH, C2 and C5), 64.9 (2CH, C3 and C4), 69.4
(5CH, Cp), 94.9 (C, C1, C-N), 112.5 (CH, Ar), 118.0 (CH, Ar), (5CH, Cp), 94.8 (C, C1, C-N), 126.0 (CH, C4’ or C5’), 126.6 (CH,
118.6 (CH, Ar), 129.8 (CH, Ar), 136.4 (C, C1’, C-C=O), 160.2 (C, C6’), 130.2 (CH, C4’ or C5’), 131.3 (CH, C3’), 136.3 and 136.7 (C,
C3’, C-OMe), 165.4 (C, C=O).
C2’, C-Me and C, C1’, C-C=O), 168.1 (C, C=O).
N-Ferrocenyl-2-naphthalenecarboxamide (2-Naph). The
3-Chloro-N-ferrocenylbenzamide
(2-3Cl). The general
procedure 1 starting from 3-chlorobenzamide (0.17 g) gave 2- general procedure 1 starting from 2-naphthalenecarboxamide
3Cl (eluent: petroleum ether-AcOEt 90:10; Rf = 0.38) in 85% (0.19 g) gave 2-Naph (eluent: petroleum ether-AcOEt 70:30; Rf
yield (0.23 g) as an orange solid: mp 170-172 °C; IR (ATR) 671, = 0.60) in 22% yield (82 mg) as an orange solid: mp 208-210 °C;
699, 747, 777, 801, 815, 827, 881, 911, 936, 1003, 1017, 1035, IR (ATR) 682, 711, 761, 773, 811, 821, 863, 905, 937, 957,
1105, 1136, 1270, 1292, 1349, 1365, 1389, 1407, 1480, 1558, 1003, 1017, 1028, 1108, 1133, 1201, 1236, 1256, 1273, 1293,
1597, 1643, 3096, 3301 cm-1; 1H NMR (CDCl3)
and H4), 4.21 (s, 5H, Cp), 4.75 (s, 2H, H2 and H5), 7.29 (br s, cm-1; H NMR ((CD3)2SO)
4.09 (s, 2H, H3 1350, 1366, 1387, 1475, 1506, 1556, 1628, 1637, 3103, 3315
1
4.04 (t, 2H, J = 1.8 Hz, H3 and H4),
1H, NH), 7.39 (t, 1H, J = 7.7 Hz, H5’), 7.49 (d, 1H, J = 7.7 Hz, 4.16 (s, 5H, Cp), 4.85 (t, 2H, J = 1.8 Hz, H2 and H5), 7.60-7.65
H4’), 7.67 (d, 1H, J = 7.6 Hz, H6’), 7.79 (s, 1H, H2’); 13C NMR (m, 2H, Ar), 7.99-8.04 (m, 3H, Ar), 8.08 (dd, 1H, J = 6.8 and 2.1
(CDCl3)
61.9 (2CH, C2 and C5), 65.1 (2CH, C3 and C4), 69.5 Hz, Ar), 8.52 (s, 1H, H1’), 9.91 (s, 1H, NH); 13C NMR ((CD3)2SO)
(5CH, Cp), 94.8 (C, C1, C-N), 125.1 (CH, C6’), 127.3 (CH, C2’), 61.2 (2CH, C2 and C5), 64.0 (2CH, C3 and C4), 68.8 (5CH, Cp),
130.2 (CH, C5’), 131.8 (CH, C4’), 135.1 (C, C3’), 136.6 (C, C1’, C- 95.9 (C, C1, C-N), 124.3 (CH, Ar), 126.8 (CH, Ar), 127.5 (CH, Ar),
C=O), 164.3 (C, C=O). Crystal data for 2-3Cl. C17H14ClFeNO, M = 127.6 (CH, Ar), 127.6 (CH, Ar), 127.9 (CH, Ar), 128.9 (CH, Ar),
339.59, monoclinic, P 21/c, a = 14.4453(9), b = 10.4926(5), c = 132.1 (C, Ar), 132.1 (C, Ar), 134.1 (C, Ar), 164.9 (C, C=O).
10.0119(6) Å,
= 105.996(2) °, V = 1458.74(14) Å3, Z = 4, d =
N-(Ferrocenyl)ferrocenecarboxamide (2-Fc). The general
1.546 g cm-3, μ = 1.213 mm-1. A final refinement on F2 with procedure 1 starting from ferrocenecarboxamide (0.25 g) gave
3327 unique intensities and 193 parameters converged at 2-Fc (eluent: petroleum ether-AcOEt 50:50; Rf = 0.11) in 78%
ωR(F2) = 0.0720 (R(F) = 0.0310) for 2899 observed reflections yield (0.34 g) as an orange solid: mp 202-204 °C (lit.60 210-230
with I > 2σ(I). CCDC 2014642.
°C (dec.)); IR (ATR) 674, 692, 766, 809, 840, 877, 933, 1000,
N-Ferrocenyl-4-fluorobenzamide
procedure 1 starting from 4-fluorobenzamide (0.15 g) gave 2- 1385, 1411, 1453, 1484, 1554, 1633, 3102, 3315 cm-1; H NMR
(
2-4F). The general 1019, 1042, 1052, 1107, 1153, 1222, 1247, 1286, 1349, 1362,
1
This journal is © The Royal Society of Chemistry 20xx
New J. Chem., 2020, 00, 1-3 | 9
Please do not adjust margins